Short peptide motifs in unstructured regions of clathrin-adaptor proteins recruit clathrin to membranes to facilitate post-Golgi membrane transport. Three consensus clathrin-binding peptide sequences have been identified and structural studies show that each binds distinct sites on the clathrin heavy chain N-terminal domain (NTD). A fourth binding site for adaptors on NTD has been functionally identified but not structurally characterised. We have solved high resolution structures of NTD bound to peptide motifs from the cellular clathrin adaptors β2 adaptin and amphiphysin plus a putative viral clathrin adaptor, hepatitis D virus large antigen (HDAg-L). Surprisingly, with each peptide we observe simultaneous peptide binding at multiple sites on NTD and viral peptides binding to the same sites as cellular peptides. Peptides containing clathrin-box motifs (CBMs) with the consensus sequence LΦxΦ[DE] bind at the 'arrestin box' on NTD, between β-propeller blades 4 and 5, which had previously been thought to bind a distinct consensus sequence. Further, we structurally define the fourth peptide binding site on NTD, which we term the Royle box. In vitro binding assays show that clathrin is more readily captured by cellular CBMs than by HDAg-L, and site-directed mutagenesis confirms that multiple binding sites on NTD contribute to efficient capture by CBM peptides. K E Y W O R D S amphiphysin, arrestin, assembly polypeptide 2 (AP2), clathrin-mediated endocytosis, endocytosis, hepatitis D virus 1 | INTRODUCTION Clathrin mediates vesicular transport between post-Golgi membranes in eukaryotes and is targeted to specific membranes by interactions with clathrin adaptor proteins. 1-3 Individually these interactions are weak, 4 but because clathrin polymerization drives the growth of a network of available binding sites, a wide range of adaptors and accessory factors may be recruited and retained at sites of coated pit formation. 2,5-7 Clathrin:adaptor interactions are typically driven by linear peptide motifs in the unstructured regions of clathrin adaptors that bind the N-terminal β-propeller domain (NTD) of the clathrin heavy chain at several distinct sites (reviewed in reference 8): the "clathrin-box motif" (CBM), consensus sequence LΦxΦ[DE] (where x denotes any amino acid, Φ denotes a bulky hydrophobic residue and [DE] is a glutamate or aspartate), binds in a groove between blades 1 and 2 of the NTD β-propeller 3,9,10 ; and the "W box" consensus PWxxW, binds the cleft near the centre of the NTD β-propeller. 11,12 Thirdly, an extended surface loop of the arrestin 2 long isoform (arrestin2L) has been shown to occupy the "arrestin box", a site lying between blades 4 and 5 of the NTD that binds peptides with consensus [LI][LI]GxL. 13 More recently, a fourth adaptor binding site on the clathrin NTD, between blades 6 and 7, was defined by Willox and Royle 14 on the basis of functional experiments in HeLa cells expressing clathrin heavy chain mutated in the NTD. This last study found that even a single functional NTD site was sufficient to sustain transferrin uptake. The observation that any individual binding site on NTD is sufficient to sustain clathrin-mediated endocytosis of the transferrin receptor raises several questions. Does it reflect promiscuity in the binding of clathrin-interaction motifs, such that an individual
clathrin-binding motif can bind to different sites on NTD, or does it instead suggest intrinsic redundancy in the recruitment of adaptors such that endocytosis still proceeds even when an entire 'class' of clathrin-binding motif is prevented from binding clathrin? Previous studies suggest the latter, as each peptide binding site on clathrin characterized to date has a distinct consensus binding motif. 10, 12, 13 However, recent studies have suggested that the binding of peptides to clathrin may be promiscuous. 14, 15 Promiscuity of CBM peptides for multiple sites on clathrin is relevant in the context of host:pathogen interactions, as it has previously been observed that viruses contain motifs resembling cellular CBMs that interact with clathrin in cells. These viral proteins have the ability to sequester clathrin, thus preventing endocytosis. 16, 17 In the case of hepatitis D virus (HDV), which harbours a putative CBM sequence in the C-terminal region of the large antigen protein (HDAg-L), the presence of the clathrin binding motif seems essential for production of virus particles. 18 If viral CBM peptides bind only to the clathrin box on NTD it would be possible to blockade this site using a small molecule inhibitor. 19 This blockade would prevent virus hijacking of clathrin without perturbing cellular endocytosis, which can proceed when binding to the NTD "clathrin box" site is disrupted. 14 However, if viral CBMs bind multiple sites on NTD with comparable affinities then small molecule interventions are unlikely to succeed. We thus sought to investigate the relative affinity of cellular vs viral peptides for clathrin NTD and to compare their modes of binding. Further, we sought to investigate the potential degeneracy of clathrin binding that had been suggested by previous studies. 14, 15 Here we present high-resolution structures of clathrin NTD bound to cellular and viral peptide motifs. Surprisingly, in all cases we observe peptide binding at multiple sites on NTD. We use clathrinbinding assays and site-directed mutagenesis to qualitatively assess the binding of these peptide motifs to the different sites on NTD.
Further, we provide the first structural characterization of the putative "fourth" adaptor binding site on clathrin NTD.
| RESULTS

| Cellular clathrin-binding motifs recruit clathrin more efficiently than those from hepatitis D virus
The CBMs from the cellular proteins β2 adaptin (AP2CBM) and amphiphysin (AmphCBM), 9, 20 the W box motif of amphiphysin (Wbox), 11, 12, 20, 21 and the C-terminal extensions of HDAg-L from 2 different HDV genotypes containing putative clathrin binding motifs (HDAg-L1 and HDAg-L2, respectively) 16, 18 were fused to glutathione S-transferase (GST) ( Figure 1A ) and immobilized on glutathione resin for use in "GST pull-down" experiments to capture clathrin purified from pig brain. In addition, to aid comparison with previous biochemical studies, 11 an extended amphiphysin CBM construct (termed Amph4T1) was used in which the clathrin-binding motif is followed by the amino acids "LERPHRD" arising from the XhoI cloning site and subsequent vector-derived nucleotides. 22 Consistent with previous studies, 11, 12 clathrin was efficiently captured by GST fused to AP2CBM, AmphCBM, Amph4T1 or the amphiphysin Wbox, while it was not significantly captured by GST alone ( Figure 1B) . Interestingly, clathrin was not efficiently captured by GST fused to either of the HDAg-L C-terminal extensions tested ( Figure 1B ).
To facilitate subsequent mutational work the N-terminal domain (NTD) of bovine clathrin heavy chain (100% amino acid identity to human clathrin heavy chain NTD), fused to a His 6 affinity tag at the N terminus and to the dimerization domain of NF-κB essential modulator (NEMO) 23 at the C terminus, was purified following expression in Escherichia coli. This His-NTD-NEMO protein binds GST-AP2CBM much more efficiently than His-NTD lacking the NEMO oligomerization domain ( Figure S1A ). We ascribe this to increased avidity of binding, as His-NTD-NEMO is capable of oligomerizing at higher concentrations whereas His-NTD is monomeric ( Figure S1 ). As observed using purified clathrin, recombinant His-NTD-NEMO is efficiently pulled-down by GST-AP2CBM, GST-AmphCBM, GST-Amph4T1 and GST-Wbox ( Figure 1C ). His-NTD-NEMO is weakly pulled down by GST-HDAg-L1, whereas GST-HDAg-L2 does not pull down His-NTD-NEMO any more efficiently than does GST alone. FIGURE 1 Cellular and viral peptide motifs bind clathrin N-terminal domain (NTD) to different degrees. A, Glutathione S-transferase (GST) fusions of clathrin-binding peptides used in this study. Clathrinbox motifs (CBMs) are aligned in bold. Amph4T1, human amphiphysin I CBM plus additional residues derived from the expression vector 22 ; AmphCBM, human amphiphysin I CBM; AP2CBM, CBM from flexible hinge of β2 adaptin subunit of human AP2; HDAg-L1, putative CBM from clade I hepatitis D virus large antigen; HDAg-L2, putative CBM from clade II hepatitis D virus large antigen; Wbox, human amphiphysin W box binding motif. B, Capture ("GST pull-down") of purified clathrin by GST-tagged clathrin-binding peptides. Clathrin (input) was incubated with glutathione sepharose pre-loaded with GST-tagged "bait" proteins. After washing, proteins bound to the beads (pellet) were subjected to SDS-PAGE and immunoblotting (WB) using an antibody that recognizes clathrin NTD (αNTD). C, Capture of His-NTD-NEMO by GST-tagged clathrin binding peptides. Purified recombinant His-NTD-NEMO was used in GST pull-down experiments as in (B).
| CBMs of cellular and viral peptides bind multiple sites on the clathrin NTD
To gain structural insight into the binding of cellular and viral peptides, recombinant NTD was crystallized in the presence of peptides corresponding to CBMs of β2 adaptin and amphiphysin, the CBM region of the non-natural Amph4T1 sequence, and the putative CBMs of HDAg-L1 and HDAg-L2. These co-crystallization experiments were performed using high concentrations (3.4-3.6 mM) of clathrin-binding peptide to ensure saturation of the peptide binding sites. The structures of all co-crystals were solved and refined to high resolution (Table 1 ) and, surprisingly, in all cases electron density consistent with the presence of peptide bound to NTD could be observed at more than 1 locus on NTD ( Figure 2 ).
In all the structures presented a peptide could be observed at the "clathrin box", lying between blades 1 and 2 of the NTD β-propeller fold ("clathrin box", Figure 2 ). For the cellular peptides (AP2CBM pep , AmphCBM pep and Amph4T1 pep ) the binding is similar to that previously described, 10 In addition to binding at the clathrin box, we observed significant binding of the cellular peptides (AP2CBM pep , AmphCBM pep and Amph4T1 pep ) at the "arrestin box", which lies between blades 4 and 5 of the NTD β-propeller fold ("arrestin box", Figure 2 ). While all 3 CBM peptides bind in the same general orientation at the arrestin box ( Figure 3 ), the molecular details of these interactions differ from the interaction seen between NTD and the extended surface loop of the arrestin 2 long isoform (arrestin2L). 13 Most notably, the directionality of the peptide chain is reversed. The first 2 leucine residues of each CBM (LΦxΦ[DE]) bind in a hydrophobic cavity lined by the side chains of NTD residues W164, L183, S185, R188, V190, I194, F216, I231 and V233 plus the peptide backbones of Y184 and S191 ( Figure 3B ). The position occupied by these 2 peptide leucine side chains is very similar to that occupied by arrestin2L residues L338 and L335 (residues 5 and 2 of the [LI][LI]GxL arrestin box consensus motif, respectively) in the complex with NTD, despite the fact that in the arrestin2L:NTD complex the peptide backbone adopts a vastly different conformation to accommodate the 2 intervening amino acid residues ( Figure 3C ). In the structures presented here the side chain oxygen atom of NTD residue Q192 forms hydrogen bonds with the backbone amide protons of these 2 leucine residues (LΦxΦ[DE]) and the side chain nitrogen atom of Q192 forms a hydrogen bond with the carbonyl oxygen of the second leucine (LΦxΦ [DE] (Table S1 ). However, in all cases a single orientation of the peptide could be modelled with good stereochemistry and an acceptable fit to electron density ( Figure 4A ).
The surface residues bound by peptides at the Royle box are highly conserved amongst eukaryotic clathrin sequences ( Figure 4B ).
Binding at the Royle box ( Figure 4C Figure 4C ). In addition, unlike the binding of peptides to the clathrin and arrestin boxes, where the same side chains of the CBM sequence form key interactions, we note that residues outside the CBM consensus sequence also form extensive interactions at the Royle box.
To investigate whether the absence of AmphCBM pep binding at the Royle box arose from an absence of stabilizing residues Cterminal to the CBM motif, we solved the structure of NTD in complex with a longer sequence containing the human amphiphysin I CBM (AmphCBMlong pep , sequence ETLLDLDFDPFK; Table S2 ). As observed for AmphCBM pep , AmphCBMlong pep bound NTD at the CBM and arrestin boxes but not at the Royle box ( Figure S2 ).
| Multiple interaction sites on clathrin NTD contribute to peptide binding in vitro
A series of His-NTD-NEMO constructs with mutations at each of the 4 peptide binding sites on NTD were generated to probe whether all the interactions observed in the crystal structures contribute to binding in a biochemical context, or whether binding can be explained by a single dominant binding interaction. The mutations introduced at each site were informed by the crystal structures presented above and by previous studies ( Figure 5A and Table 2 ). To confirm that these mutations did not introduce defects in NTD folding, the secondary structure and thermal stability of these mutants was probed by circular dichroism (CD) spectroscopy and differential scanning fluorimetry (DSF, a.k.a. Thermofluor), respectively. The CD spectra of mutants were very similar to that of wild-type NTD ( Figure S3 ), confirming that they had the correct secondary structure composition.
However, DSF showed a number of mutants to have melting temperatures significantly lower than the wild-type protein, consistent with disrupted folding, and these mutants were thus not considered further ( Figure 5B ).
A selection of the correctly folded mutants was tested for ability to bind the cellular clathrin-binding motifs in GST pull-down experiments. Given the modest ability of GST-HDAg-L1 and -L2 to capture His-NTD-NEMO ( Figure 1C ) we limited our analysis to the cellular peptide sequences (GST-AP2CBM, GST-AmphCBM, GST-Amph4T1
and GST-Wbox). Figure 5C shows that mutations at the W box (I154Q and I152L + I154Q) severely disrupt the ability of GST-Wbox to capture His-NTD-NEMO, consistent with previous studies. 12 His-NTD-NEMO with mutations at the clathrin box was less efficiently captured by GST-AP2CBM, the defect being most pronounced for the Q89A + F91K mutant, but capture of these mutants by GST-AmphCBM or GST-Amph4T1 was largely unperturbed ( Figure 5C ).
Similarly, His-NTD-NEMO mutated at the arrestin box (Q192Y) was captured less efficiently by GST-AP2CBM but the capture of this mutant by GST-AmphCBM or GST-Amph4T1 was not significantly changed ( Figure 5C ).
To test whether mutation at more than 1 peptide binding site further reduced capture by cellular CBM peptides, His-NTD-NEMO constructs with mutations at multiple binding loci were generated.
All these 'compound mutants' had CD spectra similar to that of the wild-type protein ( Figure S3 ) and melting temperatures within 3 K of the wild-type protein ( Figure 5B ), consistent with the compound mutants being well-folded. As shown in Figure 5D , 
| The arrestin motif of AP2 can also bind multiple sites on clathrin NTD
The hinge region of the assembly polypeptide 2 (AP2) complex β2 adaptin subunit contains 2 overlapping clathrin-binding motifs, a CBM and an arrestin-box motif ( Figure 6A ). However, the CBM motif can bind at the arrestin box in addition to binding at the clathrin box ( Figure 2 ) and both such interactions contribute to NTD recruitment ( Figure 5D ). We therefore sought to compare the NTD binding of the β2 adaptin arrestin-box motif to that of the β2 adaptin CBM.
Two GST-tagged peptide constructs containing the arrestin-box motif of β2 adaptin (GST-AP2arrL and GST-AP2arrS) were generated ( Figure 6A ). Both contained the β2 adaptin arrestin-box motif (LLGDL) but, to avoid the potentially confounding issue of a carboxylate group immediately following the final residue of the motif, the sequences of their C-terminal residues differed: AP2arrS had the subsequent "L" residue of β2 adaptin appended to the arrestin-box motif, while AP2arrL had the residues "ASS" appended, corresponding to the residues that follow the LLGDL arrestin-box motif of arrestin2L. 13 We compared the ability of GST-AP2CBM, GST-AP2arrS and GST-AP2arrL to capture either wild-type His-NTD-NEMO or a mutant (Q98A + F91K + F9W) where the clathrin and Royle boxes, but not the arrestin box, had been disrupted. Figure 6B shows that GST-AP2CBM and GST-AP2arrS capture wild-type and Q98A + F91K + F9W His-NTD-NEMO more efficiently than does AP2arrL, suggesting that the arrestin-box motif (LLGDL) alone binds the arrestin box more 13 NTD is shown as in (B) and arrestin2L residues 332-340 are shown as sticks with cyan carbon atoms. Note that in (B) the direction of the bound peptides is right (N terminus) to left (C terminus), whereas in (C) the peptide chain between residues L334-L338 runs in the opposite direction.
weakly than does the CBM or an extended arrestin motif (LLGDLL) containing the first 2 residues of the overlapping CBM. However, these experiments also show that GST-AP2arrL and GST-AP2arrS capture wild-type His-NTD-NEMO much more efficiently than they do the Q98A + F91K + F9W mutant, consistent with the β2 adaptin arrestin-box motif binding to either the clathrin or Royle boxes in addition to the arrestin box.
| DISCUSSION
This study presents the structure of the clathrin heavy chain NTD solved in the presence of cellular and viral clathrin-binding peptides.
In all cases, we observe that these peptides bind promiscuously to more than one site on the clathrin NTD surface. This differs from previous high-resolution structural characterizations of peptide binding Figure 2 . The surface of clathrin NTD is shown, coloured from high (green) to low (white) surface residue hydrophobicity, with outlines of selected surface side chains shown in grey. A hydrophobic NTD surface pocket that is occupied by hydrophobic residues of all three peptides is marked by a dotted line. The peptide sequences used for co-crystallization are structurally aligned at the bottom of the panel. The directionality of the bound peptides is indicated. Residues that could be confidently modelled in the structures are highlighted and residues that form side chain interactions with NTD surface pockets are printed in bold type. D, Cellular and viral peptides bind near NTD residues functionally implicated in clathrin-mediated endocytosis. The surface of NTD (grey) is oriented as in the right image of (A) with residues mutated by Willox and Royle 14 (light and dark purple) or in this study (pink) highlighted. The Amph4T1 pep peptide is shown as spheres. Inset shows the Amph4T1 pep peptide (sticks with yellow carbon atoms) bound to NTD (grey, ribbon with selected side chains shown as sticks). The carbon atoms of residues substituted in clathrin mutants that disrupt transferrin uptake, 14 a proxy for clathrin-mediated endocytosis, are dark purple while those of residues where substitution does not affect transferrin uptake are light purple. The side chain of F9, mutated in this study, is coloured bright pink.
to clathrin NTD: structures of NTD solved in the presence of β3 adaptin and β-arrestin 2 CBMs showed binding only at the clathrin box, 10 only the W box site is occupied in the structure solved in the presence of a peptide derived from the "second" (PWDLW) clathrinbinding motif of amphiphysin, 12 and the structure of NTD in complex with a long splice form arrestin 2 (arrestin2L) shows binding of 2 different peptide motifs at the clathrin and arrestin box sites. We observe that the CBMs of β2 adaptin, amphiphysin and HDAg-L2
bind to both the clathrin and arrestin box sites. Further, we provide the first structural characterization of the putative fourth and final peptide binding site on clathrin NTD, 14 which we term the Royle box.
| The arrestin box binds linear CBM peptides
The structure of arrestin2L bound to clathrin NTD revealed two different peptide epitopes bound at the clathrin and arrestin boxes. 13 
FIGURE 5
Mutation at single or multiple sites on clathrin N-terminal domain (NTD) disrupts binding to peptide motifs. A, Ribbon representation of NTD (grey) showing the location of residues that were mutated on their own or in combination to disrupt peptide binding at the clathrin box (blue), arrestin box (green), W box (orange) and Royle box (purple). B, Thermal stability of single-or multiple-site mutations of NTD as determined by differential scanning fluorimetry. The melting temperatures (T M ) of mutants relative to that of wild-type His-NTD are shown (error bars represent the standard deviation of measurement in triplicate). Mutations that perturb the T M by more than 3 K (dotted line) were not considered further. C and D, Capture of NTD mutants by glutathione S-transferase (GST)-tagged clathrin-binding peptides. Purified recombinant wild-type or mutant His-NTD-NEMO was incubated with glutathione sepharose pre-loaded with GST-tagged "bait" proteins. After washing, proteins bound to the beads (pellet) were subjected to SDS-PAGE and immunoblotting (WB) using an antibody that recognizes clathrin NTD (αNTD). The epitope bound at the arrestin box comprised an 8 amino acid surface loop that connects 2 adjacent anti-parallel beta strands of arrestin2L: this loop thus necessarily forms a relatively tight turn at its apex. The key molecular interactions are formed by three leucine side chains (L334, L335 and L338) from the arrestin2L loop that are adjacent in space ( Figure 3C ), but not consecutive in sequence, and biochemical studies defined the consensus binding sequence of this loop as [LI][LI]GxL. 13 The structures presented here show that CBM peptides, matching the LΦxΦ[DE] CBM consensus sequence, also bind NTD at the arrestin box ( Figure 2 ) and that this interaction contributes to binding in vitro ( Figure 5 ). Interestingly, the molecular determinants of binding are conserved between the arrestin2L loop and the CBM peptides: hydrophobic leucine or isoleucine side chains bind the groove between NTD β-propeller blades 4 and 5, occupying roughly equivalent spatial positions (Figure 3 ). However, the peptide backbone topology differs substantially as does the spacing between the crucial leucine/isoleucine residues. We therefore propose that the consensus sequence for binding at the arrestin box is likely to be contextdependent. In the case of arrestin2L, the amino acids that mediate binding are partly determined by the constrained nature of the surface loop. However, when presented as linear motifs, as is likely to be the biological context of the β2 adaptin, epsin 1 and amphiphysin CBM epitopes, 3, 4, 9, 21, 26 peptides that conform to the LΦxΦ[DE] CBM consensus sequence can also bind the arrestin box.
Our structural characterization of CBM peptides bound promiscuously at multiple sites on clathrin NTD is largely consistent with a recent biophysical study showing promiscuous binding of long peptides derived from β2 adaptin and AP180 at the clathrin, arrestin and W boxes of NTD. 15 However, while the long β2 adaptin peptide used in the biophysical study harboured both CBM (LLNLD) and arrestin2L (LLGDL) consensus sequences, the β2 adaptin CBM (AP2CBM) peptide used here contains only a CBM. We observe that combining mutations at the arrestin and clathrin boxes completely abolishes the ability of the AP2CBM to capture NTD in GST pulldown assays, confirming that CBM peptides bind promiscuously to both sites. Unlike the previous biophysical study, peptide binding at the W box was not observed in any of the crystal structures presented here. We ascribe this to the use of much longer peptides in the biophysical study that may harbour additional, non-canonical W box binding motifs.
Given the similar molecular determinants of linear peptide binding at the clathrin and arrestin boxes, it is perhaps surprising that binding at the arrestin box was not observed in the previous cocrystallization study that used the β3 adaptin and β-arrestin 2 CBM peptides. 10 However, we note the prior study used a lower molar excess of peptide (4-fold excess versus 7-to 10-fold excess used here). Further, the extended cryo-protection protocols employed in the prior study, using cryo-preservative solutions without added peptide, may have facilitated dissociation of bound peptides from loweraffinity sites and thus removed evidence of their binding.
| Structural characterization of the Royle box
As observed at the arrestin box (above), the molecular determinants In accordance with previous functional studies, 14 all three structures of peptides bound at the Royle box presented here show binding at a conserved surface patch that lies between blades 6 and 7 of the NTD β-propeller ( Figure 4B ). The bound peptides all wrap around the hydrophobic side chain of NTD residue F9, which also lines the hydrophobic pocket central to the interaction of peptides at the Royle box ( Figures 4C and 4D ). Mutation of F9 to the bulkier residue tryptophan does not destabilize NTD ( Figure 5B ) but is able to diminish binding to GST-Amph4T1 when combined with mutations at the Figure 4D ). Residue Q14 lies on the same short stretch of β-sheet as E11, the side chains of these two residues forming a hydrogen bond, while Q16 and N17 lie on the surface of a short α-helix immediately following Q14 ( Figure 4D ). The thermal stability of purified Q14D + Q16M + N17S NTD is slightly higher than the wild-type NTD ( Figure 5B 
| HDV peptides bind the same sites on NTD as cellular peptides
Previous studies showed that GST fused to residues 198-210 of HDAg-L, comprising the majority of the HDAg-L C-terminal extension that is expressed following editing of the HDV RNA antigenome, 27 is capable of capturing clathrin heavy chain from cell lysates. 16 Further, mutation of a putative CBM sequence in this C-terminal extension prevented both co-immunoprecipitation of clathrin heavy chain from transfected cells and the formation of virus-like particles (VLP). 18 It was therefore concluded that HDAg-L is a novel viral clathrin adaptor-like protein. 16, 18 We sought to extend this observation by probing whether cellular and HDAg-L peptides bind the same or different sites on clathrin NTD, with a view to developing smallmolecule inhibitors of the HDAg-L interaction with clathrin NTD that would restrict HDV replication.
Our structural results show that peptides containing the putative CBMs of two distinct HDAg-L sequences (HDAg-L1 pep and HDAg-L2 pep ) bind the same sites on clathrin NTD as cellular CBM peptides, binding at the clathrin box, the Royle box and (for HDAg-L2 pep ) the arrestin box ( Figure 2 ). However, GST pull-down experiments performed with either purified clathrin or an oligomerized form of the NTD (His-NTD-NEMO) showed that these viral peptides capture NTD much less efficiently than do cellular CBM epitopes (Figure 1B,C) . Previous cell-based studies showed that mutation of HDAg-L1 L199 to alanine severely reduced VLP production and clathrin co-immunoprecipitation. 18 This is consistent with our structure, as L199 forms extensive hydrophobic contacts at both the Royle and clathrin boxes (Figure 2 ). HDAg-L1 mutation D203A also diminished VLP production and coimmunoprecipitation with clathrin, but in the structures presented here this residue is consistently disordered. It is thus unclear whether this mutation directly affects binding of HDAg-L to clathrin or has some secondary effect. Previous biochemical studies of HDAg-L peptides binding to purified NTD also suggested that both L199 and D203 are important for the interaction. 16, 28 However, these experiments should be viewed with caution as they utilized an extremely short NTD construct (residues 1-107) that not only lacks both the Royle and arrestin box sites but also spans only the first two blades of the NTD β-propeller and is thus highly unlikely to be correctly folded.
Taken together, our results confirm that the putative CBM peptides from HDAg-L can directly bind clathrin NTD, but do so weakly. It is therefore unclear whether these viral CBM-like epitopes directly promote recruitment of clathrin heavy chain in vivo or whether they act synergistically with other clathrinadaptor proteins.
| Degeneracy of clathrin-binding peptide motifs
Our structural ( 
| Dynamics of association between clathrin terminal domain and adaptor peptides in coated pits
The results presented in this study underline the dynamic nature of motifs. Individually, these interactions are of low affinity. 4, 15 Proteins typically bind to both specific and non-specific sites with similar association rates (k on ), with differential affinity conferred by differing rates of dissociation (k off ). 29 Weak bimolecular interactions in the micromolar affinity range, such as those between clathrin and its adaptors, typically correspond to dissociation rates of about 1 second or a halftime of dissociation of~0.7 seconds. 29 This is significantly shorter than the timescale of productive clathrin-coated pit assembly and deformation, which occurs over the course of~90 seconds. 30 Thus, we would expect adaptors to display rapid cycles of binding to and dissociation from individual binding sites on clathrin, allowing recruitment of a multitude of different adaptor molecules to any given clathrin terminal domain. It is also possible that plasticity in clathrin motif binding allows individual adaptors harbouring multiple clathrininteraction motifs, such as epsin, 22 to bind multiple sites on the clathrin N-terminal domain simultaneously, thereby increasing their apparent affinity. However, as we are not yet able to define a consensus binding sequence for the Royle box, and considering the degenerate sequence requirements for binding at the clathrin or arrestin boxes, it is unclear how frequently clathrin adaptors might be able to employ such a mode of binding.
In summary, we have shown that cellular CBM peptides bind degenerately to multiple sites on clathrin, we define a set of NTD mutations at each of the 4 peptide binding sites that do not disrupt the NTD fold, and show in biochemical assays that multiple sites contribute to binding of NTD by cellular clathrin-binding peptides. In addition, we find that viral CBM peptides bind the same sites on NTD as cellular peptides, albeit much more weakly.
Finally, we present the first structural characterization of the Royle box, the fourth and final functional peptide binding site on the clathrin NTD. 
| MATERIALS AND METHODS
| Constructs and mutagenesis
| Protein expression and purification
A clathrin-coated vesicle fraction was isolated from pig brains essentially as described. 32 Coat proteins were stripped from the vesicles 33 Figure S1 ), which were both were snap-frozen in liquid nitrogen as described above.
| Crystallization, data collection, structure determination and analysis
Crystals were grown at 20 C by sitting drop vapour diffusion. Cla- Phaser. 45 Manual model building was performed using COOT 46 and the models were refined using REFMAC5. In all structures, the peptides were modelled after initial improvement of the peptide-free structure. The geometric quality of the models was improved by consulting the validation tools in COOT as well as the programmes Mol-Probity 47 and WHAT_CHECK. 48 Structure factors and final refined models have been deposited with the Protein Data Bank as listed in Table 1 and Table S2 . Feature-enhanced maps, which have reduced model bias and optimized scaling to ease comparison of strong and weak features, were calculated using phenix.fem. 24, 49 Evolutionary conservation of amino acids was estimated using ConSurf 50 with default parameters and chain A of the refined NTD:Amph4T1 pep structure as an input model. PyMOL (Schrodinger) was used to generate molecular graphics and figures were assembled using Inkscape (https://inkscape.org/).
| Capture (GST pull-down) assays and immunoblotting
All steps of the clathrin or His-NTD-NEMO capture assays were performed at 4 C using a previously published protocol 11 
